Guobin Weng

Guobin Weng


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2023 in Aging
Verified
Journal Article
Open access
PDF file
SHShuaishuai Huang
Shuaishuai Huang
CCCongbo Cai
Congbo Cai
KZKena Zhou
Kena Zhou
XWXue Wang
Xue Wang
DCDong Cen
Dong Cen
GWGuobin Weng
Guobin Weng
Objective: Renal clear cell carcinoma (ccRCC) is the most common type of renal cancer. Here we aim to explore the prognosis and immunotherapeutic value of copper death-related gene Dihydrolipoamide S-acetyltransferase (DLAT) in ccRCC. Methods: The mRNA and protein expressions and methylation level of DLAT, as well as the relation of DLAT to survival prognosis, clinical characteristics, biological function, and immune microenvironment and responses in patients with ccRCC were evaluated using multiple databases. In addition, 75 paired ccRCC tissue samples and 3 kinds of cell lines were tested for experimental validation. Results: Bioinformatics analysis of multiple databases, qRT-PCR, and western blot verified that DLAT expression in ccRCC was lower than that in paracancerous tissues. Patients with low expression of DLAT had a lower survival rate, worse clinical prognosis, stronger immune cell infiltration and expression of immunosuppressive points, and higher tumor immune dysfunction and exclusion (TIDE) scores. Conclusions: DLAT was identified as an independent prognostic factor in ccRCC and was closely related to the prognosis and immune responses of patients with ccRCC.

1 May 2018 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
LCLiangliang Chen
Liangliang Chen
JWJunjun Wei
Junjun Wei
SZShuwei Zhang
Shuwei Zhang
ZLZhongguan Lou
Zhongguan Lou
XWXue Wang
Xue Wang
GWGuobin Weng
Guobin Weng
Association of VDR gene TaqI polymorphism with the susceptibility to prostate cancer in Asian population evaluated by an updated systematic meta-analysis Liangliang Chen,* Junjun Wei,* Shuwei Zhang, Zhongguan Lou, Xue Wang, Yu Ren, Honggang Qi, Zhenhua Xie, Yirun Chen, Feng Chen, Qihang Wu, Xiaoxiao Fan, Honglei Xu, Shuaishuai Huang, Guobin Weng Department of Urologic Surgery, Ningbo Urology and Nephrology Hospital, Urology and Nephrology Institute of Ningbo University, Ningbo, China *These authors contributed equally to this work Background: The vitamin D receptor (VDR) plays a key role in vitamin-mediated signaling pathway. Emerging evidence has suggested that the VDR polymorphism may contribute to the risk of prostate cancer (PCa). However, the existing results are not conclusive in Asian population. Methods: We aim to evaluate the potential role of VDR polymorphisms on PCa of Asian population. PubMed, Scopus, Embase, Web of Science, Chinese National Knowledge Infrastructure, Wang Fang Data, and VIP Periodical were retrieved, and eligible studies (case–control or cohort study) meeting the inclusion criteria were evaluated through an updated meta-analysis using Stata13.0 software. Results: A total of 1,363 cases and 2,101 controls obtained from 13 eligible publications were eventually included in this meta-analysis. Our results show that a significant association of VDR taq1 polymorphism with PCa risk, especially in the Japanese population. In the clinical stage-stratified analysis, the pooled results revealed no significant difference in genetic polymorphisms between the local stage and control groups, whereas there was increased frequency of T allele and TT genotype in the advanced tumor stage group compared with local tumor stage or control groups. Similarly, no significant difference was seen in Gleason <7 and control groups, but the T allele and TT genotype were significantly higher in the Gleason ≥7 group compared with Gleason <7 or control groups. Conclusion: The VDR TaqI polymorphism might be associated with PCa risk in Asian population, especially in the Japanese population. Also, PCa patients carrying the T allele or TT genotype were more likely to progress to advanced stage. These results suggest that VDR TaqI polymorphisms may be potential diagnostic biomarkers for PCa susceptibility. Keywords: vitamin D receptor, polymorphism, prostate cancer, clinical stage, meta-analysis

28 September 2023 in Oncology Letters
Verified
Journal Article
Open access
PDF file
SHShuaishuai Huang
Shuaishuai Huang
MSMinyi Sun
Minyi Sun
YRYu Ren
Yu Ren
TLTing Luo
Ting Luo
XWXue Wang
Xue Wang
DCDong Cen
Dong Cen
Solamargine (SM), an active compound derived from Solanum nigrum, triggers apoptosis and inhibits the metastatic and oxidative activities of various types of tumor cells. However, the effect of SM on human renal carcinoma cells remains unknown. In the present study, the molecular mechanisms underlying the antitumor effects of SM on ACHN and 786‑O cells were elucidated. Specifically, MTT and colony formation assays were conducted to evaluate the impact of SM treatment on the proliferation of ACHN and 786‑O cells, and flow cytometry was conducted to determine the influence of SM on the apoptosis rates of these cells. In addition, the expression of target proteins was determined by western blotting. The results revealed that SM not only inhibited cell viability but also promoted the apoptosis of ACHN and 786‑O cells in a time‑ and dose‑dependent manner. Moreover, treatment of ACHN and 786‑O cells with SM significantly enhanced the caspase‑3, caspase‑8 and caspase‑9 activities. Furthermore, SM downregulated the expression of phosphorylated signal transducer and activator of transcription‑3 (p‑STAT3) and Bcl‑2 but increased the expression of cleaved caspase‑3, ‑8, ‑9 and Bax. BAY2353, a p‑STAT3 inhibitor, inhibited the viability of ACHN and 786‑O cells, increased the expression of cleaved caspase‑9 and Bax and decreased the expression of p‑STAT3 and Bcl‑2. Further experiments demonstrated that SM inhibited tumor growth in xenograft nude mice without causing specific toxicity to the major organs. Collectively, these findings indicated that SM not only inhibited the viability but also promoted the apoptosis of ACHN and 786‑O cells, through a mechanism involving downregulation of p‑STAT3 expression.

30 August 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ZGZhuangyu Guo
Zhuangyu Guo
CCCongbo Cai
Congbo Cai
KZKena Zhou
Kena Zhou
LSLingmin Song
Lingmin Song
XWXue Wang
Xue Wang
SHShuaishuai Huang
Shuaishuai Huang
SHC1 plays a crucial regulatory role in various tumors, but its significance in predicting prognosis and immune response in clear cell renal cell carcinoma (ccRCC) is yet to be determined. In this study, we conducted a bioinformatics analysis of SHC1 expression, prognosis, and immunological functions in ccRCC using multiple databases. The association between SHC1 and immune infiltration, immune escape, and immunotherapy in ccRCC was systematically established. In addition, we validated our results by western blot of tumor and adjacent-tumor samples from nine ccRCC patients, as well as three renal carcinoma cell lines compared to a normal renal cell line. Our analysis revealed that the mRNA expression level of SHC1 in ccRCC tissues is significantly higher than that in normal tissues. Consistently, western blot experiment showed ccRCC tissues and cell lines exhibit higher protein levels that normal tissues and cell lines. Importantly, patients with low expression of SHC1 demonstrated a higher survival rate, indicating that SHC1 could serve as an independent prognostic factor for predicting survival in ccRCC. Additionally, high expression of SHC1 was associated with increased severe immune cell infiltration, enhanced immune escape, and higher immunotherapy scores. Hence, SHC1 emerges as a novel and easily detectable biomarker for predicting clinical outcomes, immune escape, and immunotherapy response in patients with ccRCC.

13 November 2024 in Iranian Journal of Public Health
Verified
Journal Article
Open access
PDF file
ZGZhuangyu Guo
Zhuangyu Guo
XWXue Wang
Xue Wang
SHShuaishuai Huang
Shuaishuai Huang
GWGuobin Weng
Guobin Weng
Background: M6A RNA methylation and the tumor microenvironment (TME) have been reported to play important roles in the progression and prognosis of clear cell renal cell carcinoma (ccRCC). However, whether m6A RNA methylation regulators affect the TME in ccRCC remains unknown. Thus, we aimed to evaluate comprehensively the effect of m6A RNA methylation regulators on the TME in ccRCC. Methods: Transcriptome data of ccRCC were obtained from TCGA database. Consensus clustering analysis was conducted based on the expression of m6A RNA methylation regulators. Survival differences were evaluated by Kaplan–Meier analysis between the clusters. The DESeq2 package was used to analyze the differentially expressed genes (DEGs) between the clusters. GO and KEGG pathway analyses were performed by the ClusterProfiler R package. The CIBERSORT algorithm was used to evaluate immune infiltration. Results: The expression of 15 m6A regulators significantly differed between ccRCC and normal kidney tissues. Based on the expression of these 15 m6A regulators, two clusters were identified by consensus clustering, in which cluster 1 had better overall survival (OS). Overall, 4,429 DEGs were identified between the two clusters and were enriched in immune-related biological processes. Cluster 1 had lower immune and ESTIMATE scores, higher expression of HLA and lower expression of immune checkpoint molecules. Moreover, immune infiltration and expressions of Th1/IFNγ gene signature were also significantly different between the two clusters. Conclusion: Our study revealed m6A regulators were important participants in the development of ccRCC, with a close relationship with the TME.